The abstract is read at the publisher; the summary is JClub's.
In bipolar disorder participants, frontolimbic synaptic density measured by [11C]UCB-J SV2A PET is lower, seemingly driven by those taking psychotropic medications (BD-med).
- Why it matters: Limited in vivo evidence links frontolimbic synaptic loss to bipolar disorder, and medication effects could confound neuroimaging interpretations.
- What they did: Nineteen individuals with BD (BDI n=13; BDII n=6) and 26 healthy controls underwent parallel SV2A PET with structural and functional MRI to quantify SV2A density, GMV, and intrinsic connectivity, with exploratory medication-stratified analyses.
- The result: BD-med showed higher GMV than BD-none and lower connectivity than BD-none; SV2A and GMV correlated positively in controls but not in BD, where lower SV2A/GMV ratios were linked to greater impulsivity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.